³Ô¹ÏÍøÕ¾

Latest

Latest ³Ô¹ÏÍøÕ¾ Cancer Institute News | Page 2

  • Latest ³Ô¹ÏÍøÕ¾ Cancer Institute news stories and updates. What is happening today? All recent ³Ô¹ÏÍøÕ¾ Cancer Institute news and developments. Live coverage and timeline of ³Ô¹ÏÍøÕ¾ Cancer Institute. All you need to know about ³Ô¹ÏÍøÕ¾ Cancer Institute.
Cancer care and lessons learned from pandemic
Microcalcification ‘fingerprints’ can yield info about cancer
Simple low-dose aspirin may boost ovarian cancer survival
NIH grant to improve HIV-related cancer care abroad
Study helps explain severe graft-versus-host disease and potential solution
Ludwig Harvard imaging study reveals cellular, molecular and structural complexity of colorectal tumors
Just because someone had COVID before they had a heart attack doesn’t mean it was cause
Smoking linked to early vision loss and cataracts
Promising approach to mitigate complications of leukemia treatment
Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type1
Lynparza approved in China as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
Researchers explore use of light-activated treatment to target wider variety of cancers
Lynparza approved in Japan as adjuvant treatment for patients with BRCA-mutated HER2-negative high-risk early breast cancer
Researchers identified markers of chemotherapy resistance and outcome in triple negative breast cancer
Scientists unlock potential for small cell lung cancer blood test
Portable cancer testing expands in sub-Saharan Africa
Stomach cancer paradigm shift
Lynparza approved in EU as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
Researchers uncover unanticipated aspects of genetic regulation of different brain tumors
CPTAC renews funding for proteogenomics research at Baylor
Lynparza recommended for approval in EU by CHMP as adjuvant treatment for patients with germline BRCA-mutated HER2-negative
Goldilocks treatment window could lead to cancer therapy without harmful side-effects
Bone loss medicines linked to lower ovarian cancer rates
Ludwig Princeton’s Eileen White named co-leader of $25 million Cancer Grand Challenges team tackling cancer cachexia
Schmitz receives $3.2 million to bring supportive cancer care to rural areas
New molecular subset of pediatric liver cancer identified
Smokers who switch to e-cigarettes may adopt other healthy routines
Simones career reboot: from IT to nursing
Ludwig MSK study modeling tumor evolution reveals vulnerability for cancer prevention and therapy
Fruit snack or edible? Study finds some cannabis products look like popular snacks
NCI-COG Pediatric MATCH study shows benefit of genetic screening in refractory tumors
Flavored tobacco sales restrictions impact availability, advertising
Study shows long-term safety of genetically modified immune effector cells
Lynparza reduced risk of death by 32% in adjuvant treatment of patients with germline BRCA-mutated high-risk early breast cancer
Lynparza approved in US as adjuvant treatment for patients with germline BRCA-mutated HER2-negative high-risk early breast cancer
$2.5M grant awarded to flip switch on lung cancer drug resistance
WHO and St. Jude to dramatically increase global access to childhood cancer medicines
Common diabetes drug not effective against early-stage breast cancer, researchers say
Scientists studying new method to model bladder cancer treatments
New centre to harness data in classroom and empower learners for age of AI
Study looks at approaches for early diagnosis of pancreatic cancer
Gene signature IDs drivers of treatment resistance in metastatic breast cancer
Cancer costs U.S. more than $156 billion, with drugs leading expense
Baylor awarded NIH funding for Clinical Genome ResourceBaylor awarded NIH funding for Clinical Genome Resource
Micro-robots propelled by air bubbles and ultrasound
AI-powered microscope could check cancer margins in minutes
Unexpected discovery about stem cell immortality: study
A 20-second test to predict risk of major adverse events after surgery

© 2024 - ³Ô¹ÏÍøÕ¾